Trends in childhood type 1 diabetes incidence in Europe during 1989???2008: evidence of non-uniformity over time in rates of increase, Diabetologia, vol.6, issue.8, 2012. ,
DOI : 10.1007/s00125-012-2571-8
incidence des admissions en affection de longue durée pour diabète chez l'enfant en France, InVS. BEH, pp.44-45, 2003. ,
Incidence trends for childhood type 1 diabetes in Europe during 1989???2003 and predicted new cases 2005???20: a multicentre prospective registration study, The Lancet, vol.373, issue.9680, 2009. ,
DOI : 10.1016/S0140-6736(09)60568-7
Genetics, pathogenesis and clinical interventions in type???1 diabetes, Nature, vol.464, issue.7293, pp.1293-300, 2010. ,
DOI : 10.1038/nature08933
Analysis of islet i nflammation in human type 1 diabetes, Clin Exp Immunol, 2009. ,
Non-HLA genes (revision number 36) ,
DOI : 10.14496/dia.2104311115.36
Available from: http://www.diapedia.org, p.36, 2013. ,
Type 1 diabetes: A predictable disease, World Journal of Diabetes, vol.6, issue.3, pp.380-90, 2015. ,
DOI : 10.4239/wjd.v6.i3.380
New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes. Diabetes Care, pp.1384-90, 2009. ,
'The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors, Pediatric Diabetes, vol.21, issue.2, pp.101-108, 2006. ,
DOI : 10.1210/jc.85.12.4619
Redefining the clinical remission period in children with type 1 diabetes. Pediatr Diabetes, pp.16-25, 2004. ,
Factors predicting clinical remission in adult patients with type 1 diabetes, Journal of Internal Medicine, vol.15, issue.2, pp.155-62, 1999. ,
DOI : 10.1210/jc.75.6.1574
Young children (<5??yr) and adolescents (>12??yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor, Pediatric Diabetes, vol.315, issue.3pt1, pp.197-201, 2008. ,
DOI : 10.1055/s-2007-948214
Partial Remission Phase and Metabolic Control in Type 1 Diabetes Mellitus in Children and Adolescents, Journal of Pediatric Endocrinology and Metabolism, vol.14, issue.4, pp.435-476, 2001. ,
DOI : 10.1515/JPEM.2001.14.4.435
Shorter Remission Period in Young Versus Older Children with Diabetes Mellitus Type 1, Experimental and Clinical Endocrinology & Diabetes, vol.115, issue.1 ,
DOI : 10.1055/s-2007-948214
Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males?, European Journal of Endocrinology, vol.145, issue.6, pp.757-61, 2001. ,
DOI : 10.1530/eje.0.1450757
The Effect of Neonatal Sex Hormone Manipulation on the Incidence of Diabetes in Nonobese Diabetic Mice, Experimental Biology and Medicine, vol.202, issue.2, pp.201-206, 1993. ,
DOI : 10.3181/00379727-202-43527
Insulin sensitivity in Type??1 diabetic children and adolescents, Diabetic Medicine, vol.59, issue.3, pp.282-290, 2008. ,
DOI : 10.2337/diacare.26.1.138
Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis. Diabetes Nutr Metab, pp.246-51, 2002. ,
Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus, Diabetic Medicine, vol.15, issue.10, pp.844-50, 1998. ,
DOI : 10.1002/(SICI)1096-9136(199810)15:10<844::AID-DIA679>3.0.CO;2-A
Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group., Archives of Disease in Childhood, vol.75, issue.5, pp.410-415, 1996. ,
DOI : 10.1136/adc.75.5.410
??-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of ??-Cell Mass in Humans, Diabetes, vol.57, issue.6, pp.1584-94, 2008. ,
DOI : 10.2337/db07-1369
Factors predicting residual ??-cell function in the first year after diagnosis of childhood type 1 diabetes, Diabetes Research and Clinical Practice, vol.11, issue.1, pp.9-16, 1991. ,
DOI : 10.1016/0168-8227(91)90135-Z
Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes, Diabetes Metab, 1996. ,
??-Cell Mass and Type 1 Diabetes: Going, Going, Gone?, Diabetes, vol.57, issue.11, pp.2883-2891, 2008. ,
DOI : 10.2337/db07-1817
Type 1 diabetes as a relapsing?remitting disease? Nat Rev Immunol, pp.988-94, 2007. ,
Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care, pp.66-74, 1992. ,
Effect of genetic risk load defined by HLA-DQB1 polymorphism on clinical characteristics of ID DM in children, European Journal of Clinical Investigation, vol.5, issue.2, pp.106-118, 1995. ,
DOI : 10.1203/00006450-199305000-00016
Autoantibodies in Prediction of ?-Cell Function and Remission in Recent-Onset IDDM After Cyclosporin Treatment. Diabetes, pp.1291-1297, 1994. ,
Screening Strategies for the Identification of Multiple Antibody-Positive Relatives of Individuals with Type 1 Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.1, 2003. ,
DOI : 10.1210/jc.2002-020760
Residual ?-Cell Function 3?6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents. Diabetes Care, pp.3454-3463, 2013. ,
Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial, The Lancet, vol.372, issue.9651, pp.1746-55, 2008. ,
DOI : 10.1016/S0140-6736(08)61309-4
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes, The Lancet, vol.363, issue.9413 ,
DOI : 10.1016/S0140-6736(04)15786-3
Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 ,
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function, New England Journal of Medicine, vol.361, issue.22, pp.2143-52, 2009. ,
DOI : 10.1056/NEJMoa0904452